Legend Biotech (LEGN) Amortizatization of Intangibles (2020 - 2025)
Legend Biotech (LEGN) posted Amortizatization of Intangibles of $10.0 million for Q3 2025, up 9891.0% on a QoQ basis from $100000.0 in Q2 2025, and up 72.56% year-over-year from $5.8 million in Q3 2024.
Legend Biotech (LEGN) has 6 years of Amortizatization of Intangibles data on file, last reported at $10.0 million in Q3 2025.
- In Q3 2025, Amortizatization of Intangibles rose 72.56% year-over-year to $10.0 million; the TTM figure through Sep 2025 stood at $5.1 million (down 32.09% YoY), while the FY2024 annual figure was $1.9 million, changed 0.36% from the prior year.
- Amortizatization of Intangibles advanced to $10.0 million in Q3 2025, from $100000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $10.0 million in Q3 2025 and bottomed at -$5.7 million in Q3 2023.
- A 5-year average of $418421.1 and a median of $419000.0 in 2021 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2021 — Amortizatization of Intangibles jumped 1451.85% — and 2023, when it plunged 1307.54%.
- Year by year, Amortizatization of Intangibles stood at $419000.0 in 2021, then jumped by 104.06% to $855000.0 in 2022, then tumbled by 43.63% to $482000.0 in 2023, then slumped by 1160.17% to -$5.1 million in 2024, then soared by 295.52% to $10.0 million in 2025.
- The last three Amortizatization of Intangibles figures came in at $10.0 million (Q3 2025), $100000.0 (Q2 2025), and $128000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9.99 Mn |
| Sep 30, 2025 | 9.99 Mn |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 128,000.00 |
| Mar 31, 2025 | 128,000.00 |
| Dec 31, 2024 | -5.11 Mn |
| Dec 31, 2024 | -5.11 Mn |
| Sep 30, 2024 | 5.79 Mn |
| Sep 30, 2024 | 5.79 Mn |
| Jun 30, 2024 | 366,000.00 |
| Jun 30, 2024 | 366,000.00 |
| Mar 31, 2024 | 885,000.00 |
| Mar 31, 2024 | 885,000.00 |
| Dec 31, 2023 | 482,000.00 |
| Dec 31, 2023 | 482,000.00 |
| Sep 30, 2023 | -5.68 Mn |
| Sep 30, 2023 | -5.68 Mn |
| Jun 30, 2023 | -3.68 Mn |
| Jun 30, 2023 | -3.68 Mn |
| Mar 31, 2023 | 826,000.00 |
| Mar 31, 2023 | 826,000.00 |
| Dec 31, 2022 | 855,000.00 |
| Dec 31, 2022 | 855,000.00 |
| Sep 30, 2022 | 825,000.00 |
| Sep 30, 2022 | 825,000.00 |
| Jun 30, 2022 | 305,000.00 |
| Jun 30, 2022 | 305,000.00 |
| Mar 31, 2022 | 491,000.00 |
| Mar 31, 2022 | 491,000.00 |
| Dec 31, 2021 | 419,000.00 |
| Dec 31, 2021 | 419,000.00 |
| Sep 30, 2021 | 364,000.00 |
| Sep 30, 2021 | 364,000.00 |
| Jun 30, 2021 | 102,000.00 |
| Jun 30, 2021 | 102,000.00 |
| Mar 31, 2021 | 494,000.00 |
| Mar 31, 2021 | 494,000.00 |
| Dec 31, 2020 | 27,000.00 |
| Dec 31, 2020 | 27,000.00 |
| Sep 30, 2020 | 111,000.00 |
| Sep 30, 2020 | 111,000.00 |